Malignant lipogenesis defined by 11C-acetate PET/CT predicts prostate cancer-specific survival in patients with biochemical relapse after prostatectomy

Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting

(2016) Michael Sia et al.   CUAJ-Canadian Urological Association Journal

Laparoscopic extended pelvic lymph node (LN) dissection as validation of the performance of [11C]-acetate positron emission tomography/computer tomography in the detection of LN metastasis in intermediate- and high-risk prostate cancer

(2015) Georgios Daouacher et al.   BJU INTERNATIONAL

[11C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy

(2015) Giampiero Giovacchini et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [11C]acetate PET as a prognostic marker

(2015) Asha Leisser et al.   PROSTATE

11C-Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen-Deprivation Therapy

(2014) G. Giovacchini et al.   JOURNAL OF NUCLEAR MEDICINE

Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study

(2014) Makito Miyake et al.   Radiation Oncology

[11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy

(2014) Martin C. Schumacher et al.   Scandinavian Journal of Urology

Application of11C-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature

(2013) Beheshti Mohsen et al.   BJU INTERNATIONAL

First imaging results of an intraindividual comparison of 11C-acetate and 18F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy

(2013) Franz Buchegger et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Management of Biochemical Recurrence After Primary Treatment of Prostate Cancer: A Systematic Review of the Literature

(2013) Sanoj Punnen et al.   EUROPEAN UROLOGY

11C-Acetate PET/CT Before Radical Prostatectomy: Nodal Staging and Treatment Failure Prediction

(2013) M. Haseebuddin et al.   JOURNAL OF NUCLEAR MEDICINE

Baseline 18F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer

(2013) H. Jadvar et al.   JOURNAL OF NUCLEAR MEDICINE

Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy Outcome

(2013) Yukie Yoshii et al.   PLoS One

Metabolic alterations and targeted therapies in prostate cancer

(2010) Richard Flavin et al.   JOURNAL OF PATHOLOGY

2040 11C-ACETATE PET IMAGING OF RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: DETECTION OF RECURRENT DISEASE UNDER PSA OF 3.0 NG/ML

(2010) Nobuyuki Oyama et al.   JOURNAL OF UROLOGY

Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy

(2009) Giampiero Giovacchini et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy

(2008) Bruce J. Trock   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

1-11C-Acetate as a PET Radiopharmaceutical for Imaging Fatty Acid Synthase Expression in Prostate Cancer

(2008) A. L. Vavere et al.   JOURNAL OF NUCLEAR MEDICINE